Taxus Pharmaceuticals Holdings Inc (TXSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2017 | 06-2016 | 06-2015 | 06-2014 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6 | 29 | 14 | 4 | 1 |
| Inventories | N/A | 24 | 39 | 21 | 40 |
| TOTAL | $6 | $54 | $52 | $24 | $41 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3 | 11 | 11 | 4 | 4 |
| TOTAL | $3 | $11 | $11 | $4 | $4 |
| Total Assets | $9 | $64 | $63 | $28 | $45 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 63 | 76 | 41 | 40 | 23 |
| TOTAL | $63 | $76 | $41 | $40 | $23 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $63 | $76 | $41 | $40 | $23 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 81,500 | 81,500 | 81,500 | N/A | N/A |
| Common Shares | 1 | 1 | 1 | 10 | 10 |
| Retained earnings | -703 | -586 | -319 | -92 | -33 |
| TOTAL | $-54 | $-12 | $22 | $-12 | $22 |
| Total Liabilities And Equity | $9 | $64 | $63 | $28 | $45 |